Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer

Integrative Biology (United Kingdom)

Volumn 5, Issue 1, 2013, Pages 172-182

  Mock, J N ^a   Costyn, L J ^a   Wilding, S L ^a   Arnold, R D ^a   Cummings, B S ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; LIPOSOME; NANOPARTICLE; PHOSPHOLIPASE A2;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL STRAIN LNCAP; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG UPTAKE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 84871745650     PISSN: 17579694     EISSN: 17579708     Source Type: Journal    
DOI: 10.1039/c2ib20108a     Document Type: Article

References (32)

1. R. D. Arnold D. E. Mager J. E. Slack R. M. Straubinger Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model Clin. Cancer Res. 2005 11 8856 8865
2. M. F. Drummond A. R. Mason European perspective on the costs and cost-effectiveness of cancer therapies J. Clin. Oncol. 2007 25 191 195
3. Gr. Lambeau M. H. Gelb Biochemistry and Physiology of Mammalian Secreted Phospholipases A2 Annl. Rev. Biochem. 2008 77 495 520
4. M. Murakami Y. Taketomi Y. Miki H. Sato T. Hirabayashi K. Yamamoto Recent progress in phospholipase A research: from cells to animals to humans Prog. Lipid Res. 2011 50 152 192
5. J. R. Graff B. W. Konicek J. A. Deddens M. Chedid B. M. Hurst B. Colligan et al., Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade Clin. Cancer Res. 2001 7 3857 3861
6. W. Pruzanski P. Vadas Secretory synovial fluid phospholipase A2 and its role in the pathogenesis of inflammation in arthritis J. Rheumatol. 1988 15 1601 1603
7. L. Leistad A. J. Feuerherm M. Ostensen A. Faxvaag B. Johansen Presence of secretory group IIa and V phospholipase A2 and cytosolic group IValpha phospholipase A2 in chondrocytes from patients with rheumatoid arthritis Clin. Chem. Lab. Med. 2004 42 602 610
8. -/- mice J. Cardiovasc. Pharmacol. 2009 53 60 65
9. M. A. Bostrom B. B. Boyanovsky C. T. Jordan M. P. Wadsworth D. J. Taatjes F. C. de Beer et al., Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice Arterioscler., Thromb., Vasc. Biol. 2007 27 600 606
10. B. Rosengren A. C. Jonsson-Rylander H. Peilot G. Camejo E. Hurt-Camejo Distinctiveness of secretory phospholipase A2 group IIA and V suggesting unique roles in atherosclerosis Biochim. Biophys. Acta 2006 1761 1301 1308
11. T. L. Andresen S. S. Jensen T. Kaasgaard K. Jorgensen Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2 Curr. Drug Delivery 2005 2 353 362
12. G. Zhu J. N. Mock I. Aljuffali B. S. Cummings R. D. Arnold Secretory phospholipase A responsive liposomes J. Pharm. Sci. 2011 100 3146 3159
13. G. Zhu Y. Alhamhoom B. S. Cummings R. D. Arnold Synthesis of lipids for development of multifunctional lipid-based drug-carriers Bioorg. Med. Chem. Lett. 2011 21 6370 6375
14. Q. Dong M. Patel K. F. Scott G. G. Graham P. J. Russell P. Sved Oncogenic action of phospholipase A2 in prostate cancer Cancer Lett. 2006 240 9 16
15. M. Kallajoki K. A. Alanen M. Nevalainen T. J. Nevalainen Group II phospholipase A2 in human male reproductive organs and genital tumors Prostate 1998 35 263 272
16. J. Jiang B. L. Neubauer J. R. Graff M. Chedid J. E. Thomas N. W. Roehm et al., Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma Am. J. Pathol. 2002 160 667 671
17. S. Yamashita J. Yamashita M. Ogawa Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency Br. J. Cancer 1994 69 1166 1170
18. S. Yamashita M. Ogawa K. Sakamoto T. Abe H. Arakawa J. Yamashita Elevation of serum group II phospholipase A2 levels in patients with advanced cancer Clin. Chim. Acta 1994 228 91 99
19. S. Yamashita J. Yamashita K. Sakamoto K. Inada Y. Nakashima K. Murata et al., Increased expression of membrane-associated phospholipase A2 shows malignant potential of human breast cancer cells Cancer 1993 71 3058 3064
20. H. Kiyohara H. Egami H. Kako Y. Shibata K. Murata S. Ohshima et al., Immunohistochemical localization of group II phospholipase A2 in human pancreatic carcinomas Int. J. Pancreatol. 1993 13 49 57
21. T. Kuopio T. O. Ekfors V. Nikkanen T. J. Nevalainen Acinar cell carcinoma of the pancreas. Report of three cases APMIS 1995 103 69 78
22. Y. Oka M. Ogawa Y. Matsuda A. Murata J. Nishijima K. Miyauchi et al., Serum immunoreactive pancreatic phospholipase A2 in patients with various malignant tumors Enzyme 1990 43 80 88
23. P. Sved K. F. Scott D. McLeod N. J. King J. Singh T. Tsatralis et al., Oncogenic action of secreted phospholipase A2 in prostate cancer Cancer Res. 2004 64 6934 6940
24. G. R. Bartlett Phosphorus assay in column chromatography J. Biol. Chem. 1959 234 466 468
25. G. Haran R. Cohen L. K. Bar Y. Barenholz Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases Biochim. Biophys. Acta 1993 1151 201 215
26. J. A. Kamps H. W. Morselt P. J. Swart D. K. Meijer G. L. Scherphof Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells Proc. Natl. Acad. Sci. U. S. A. 1997 94 11681 11685
27. R. I. Geran Am. Schumach B. J. Abbott Nh. Greenber Mm. Macdonal Protocols for Screening Chemical Agents and Natural-Products against Animal Tumors and Other Biological-Systems Cancer Chemother. Rep., Part 3 1972 3 1 17
28. I. A. Aljuffali J. N. Mock L. J. Costyn H. Nguyen T. Nagy B. S. Cummings et al., Enhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer Cancer Biol. Ther. 2011 12 407 420
29. K. Hanasaki H. Arita Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2 Prostaglandins Other Lipid Mediators 2002 68-69 71 82
30. M. Menschikowski A. Hagelgans E. Gussakovsky H. Kostka E. L. Paley G. Siegert Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms Neoplasia 2008 10 279 286
31. M. Bakovic M. D. Fullerton V. Michel Metabolic and molecular aspects of ethanolamine phospholipid biosynthesis: the role of CTP:phosphoethanolamine cytidylyltransferase (Pcyt2) Biochem. Cell Biol. 2007 85 283 300
32. H. Maeda J. Wu T. Sawa Y. Matsumura K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control Release 2000 65 271 284